top of page

© 2023

Laboratory Medicine in Psychiatry and Behavioral Science, 2nd edition

American Psychiatric Publishing, Inc.

730 pages

ISBN-10 ‏ : ‎ 1615374507

ISBN-13 ‏ : ‎ 978-1615374502

Since the publication of the first edition of Laboratory Medicine in Psychiatry and Behavioral Science in 2012, there has been a proliferation of research and publication on the topic. Now, those advances are captured in this revised second edition.

Backed by years of clinical practice and research in neuropsychiatry and informed by sources that include the National Library of Medicine and the American Society of Health-System Pharmacists Drug Information book, this new volume contains detailed descriptions of more than 150 laboratory tests, 120 diseases and conditions—including, for the first time, COVID-19, 22q11.2 deletion syndrome, and DRESS syndrome—and 70 psychotropic medications.

This edition also features appendixes that include algorithms, tables, and figures that aid in understanding and interpreting various laboratory tests and their underlying biology, making it an indispensable resource for psychiatrists and other behavioral health clinicians seeking to care for adult psychiatric patients more effectively across a range of settings.

© 2017

Clinical Laboratory Medicine for Mental Health Professionals

American Psychiatric Association Publishing

388 pages

ISBN 978-1-61537-084-9

 

A revised, abridged version of the seminal work Laboratory Medicine in Psychiatry and Behavioral Science, Clinical Laboratory Medicine for Mental Health Professionals more directly address the needs of general psychiatrists and their mental health colleagues in clinical practice.

​Sections on laboratory tests, diseases and conditions, and psychotropic medications include alphabetically arranged entries, making it easy for busy clinicians to reference the updated information. For each laboratory test, the following information is provided:

  • The type of test (e.g., blood, urine, etc.)

  • An explanation of the test

  • The test's relevance to psychiatry

  • Patient preparation

  • Medical and psychiatric indications for the test

  • Numerical reference ranges

  • Critical values for test results

  • The potential meaning of abnormal results (e.g., factors that lead to increased or decreased levels)

  • Interfering factors

  • Cross-references to other tests or conditions

 

​Information on clinical diagnosis and laboratory testing is provided for diseases and conditions, and psychotropic medications are examined from both a screening and a monitoring standpoint. Extensively indexed, this guide also includes an appendix that features at-a-glance information on therapeutic and psychotropic levels, 10 rules for deciding whether an ECG is normal, and several figures covering topics relevant to tests, such as ECG waves and intervals, cholestatic injury, bilirubin cycle, and SIADH secretion.

​

Years of clinical practice and research inform both the choice of tests included and the rationale for their use, making Clinical Laboratory Medicine for Mental Health Professionals the definitive, authoritative reference for psychiatrists and other behavioral health clinicians.

© 2014

Clinical Manual of Geriatric Psychopharmacology 

American Psychiatric Association Publishing

544 pages

ISBN 978-1-58562-454-6

​

In the seven years since the first edition of Clinical Manual of Geriatric Psychopharmacology was published, dozens of new drugs have been released, and older medications have been marketed in different formulations. In addition, research on pharmacokinetics, pharmacodynamics and mechanism of action, potential interactions, and other critical topics has proceeded apace, rendering much of the information in existing guides obsolete. This new volume is both comprehensive and completely up to date, offering information unavailable elsewhere.

​

New drugs covered include asenapine, paliperidone, iloperidone, lurasidone, desvenlafaxine, vilazodone, long-acting trazodone, milnacipran, armodafinil, extended-release valproate, rotigotine transdermal, tetrabenazine, dextromethorphan, long-acting gabapentin, and transdermal buprenorphine.

​

Each chapter has a standardized format, with topics including pharmacokinetics, pharmacodynamics and mechanism of action, drug interactions, clinical use (which addresses choice of drug, alternative formulations/routes, pre-treatment evaluation, dose and dose titration, PRN use, monitoring treatment, drug levels, managing treatment resistance, switching drugs, duration of treatment, discontinuation, and overdose), adverse effects, and treatment of selected syndromes and disorders.

​

Dozens of tables, boxes, and figures organize and present complex material, such as practice guidelines, in a straightforward manner that is easy to understand and apply, and the concise, bulleted text facilitates reading and comprehension in the clinical setting.

​

Specific Drug Summaries—one-page summaries of prescribing information for individual drugs —provide fast access to critical information in a simple format.

​

Designed for residents, fellows, and all clinicians in psychiatry and medicine who diagnose and treat psychiatric and neuropsychiatric conditions affecting geriatric patients, this clinical reference can be used across all treatment settings (inpatient, outpatient, day hospital, consultation, and nursing home).

​

Meticulously referenced and grounded in the latest research, this Second Edition is the definitive guide to psychotropic use in elderly patients. Clinicians can rely confidently on its up-to-date coverage and authoritative counsel.

Laboratory Medicine in Psychiatry and Behavioral Science

 

Note: A second edition of this book was published in 2023.

 

© 2012

Laboratory Medicine in Psychiatry and Behavioral Science

American Psychiatric Publishing, Inc.

725 pages

ISBN 978-1-58562-383-9

​

Laboratory Medicine is a complex and changing field, and for the busy clinician, it is difficult to maintain an adequate working knowledge of current concepts and practices in this area—although this information is essential to excellent patient care. If you as a psychiatrist or behavioral health clinician have found yourself wondering what tests need to be performed before a new medication is initiated, what monitoring is required, or what an out-of-range laboratory value means in the behavioral medicine population, then this book is for you. If you need to remember how to diagnose SIADH or antiphospholipid syndrome or pellagra, or any other behavioral health condition diagnosed wholly or partly by lab testing, then this book is for you.

​

Laboratory Medicine in Psychiatry and Behavioral Science is the only current book of its kind on the market and the only place where psychiatrists and behavioral health clinicians can find content that is directly related to their work. The author's extensive experience in clinical psychiatry and neuropsychiatry informs not only the choice of tests, but also the rationale for their use. Among other notable features, the book:

  • Includes information on 168 different laboratory tests and 124 diseases and conditions

  • Includes a section on laboratory tests pertinent to psychotropic drug initiation and monitoring

  • Includes an appendix with useful algorithms such as Ten Rules for a Normal ECG and Medical Evaluation for ECT.

  • Provides information on what patients can expect and how to prepare for specific lab tests (e.g., the need to fast or to refrain from certain drugs or foods) so that clinicians can inform patients fully in advance of testing

  • Covers current standards of care in monitoring metabolic syndrome and other adverse effects and complications that can arise in psychiatric and behavioral medicine patients.

  • Provides easy access to information, with extensive indexing.

Clinical Manual of Geriatric Psychopharmacology

Note: A second edition of this book was published in 2014. 

© 2007

Clinical Manual of Geriatric Psychopharmacology

American Psychiatric Publishing, Inc.

829 pages

ISBN-13: 978-1585622528

ISBN-10: 1585622524

​

What do clinicians need to know to safely and effectively prescribe psychotropic medications to elderly patients? Understanding the complex pharmacological changes that occur with aging is critical to informed prescribing, yet much of today's practice in geriatric prescribing continues to be based on anecdotal evidence and case report data, instead of on much-needed controlled research studies. Navigating the vast database in geriatric psychopharmacology is a daunting task at best, leaving many clinicians overwhelmed and confused, and opening the door to potentially dangerous consequences for some of our most fragile patients. Clinicians can now turn to this definitive handbook for answers.

​

Here, three experienced pharmacologists provide a truly practical “how-to” guide to prescribing medications in the geriatric population, drawing on their own clinical experience and their reading of the literature in geriatric psychopharmacology. Unlike other hardcover-only references in this field, this concise handbook is replete with valuable advice (e.g., drug dosing, titration) for day-to-day clinical practice, including strategies for improving compliance among the elderly. Also included are unique quick-reference summaries of prescribing data on selected drugs in each class.

​

The introduction focuses on the essentials of geriatric pharmacokinetics and a general approach to geriatric prescribing, offering guidelines on how to improve compliance in the elderly. The next four chapters each cover a major psychotropic class of medications: antipsychotics, antidepressants, mood stabilizers, and anxiolytic and sedative-hypnotic medications, including information about pharmacology (baseline labs), clinical use (drug titration), side effects, and treatment. Here, at the end of each of these chapters, you'll find the unique, quick-reference summaries of prescribing data for selected drugs in each class. Also detailed here are three critical areas of geriatric psychopharmacology: treatment of substance-related disorders, movement disorders, and dementias and other cognitive syndromes. These are areas that do not fit well into the traditional organization of psychopharmacology books and that therefore have seldom been the subject of in-depth discussions elsewhere in published reference works.

​

This book is intended for geriatric and general psychiatrists, geriatric medical specialists, medical students, residents, and fellows working in all treatment settings, including inpatient, outpatient, day hospital, consultation, and nursing homes.

bottom of page